AstraZeneca Q2 Loss Widens to Rs 27.96 Crore

New Delhi: Drug firm AstraZeneca on Monday reported a net loss of Rs 27.96 crore for the second quarter that ended on September 30, 2014.

The company has posted a net loss of Rs 1.22 crore for the corresponding period a year ago.

AstraZeneca's total income from operation during the quarter under review was at Rs 114.67 against Rs 115.66 crore in the second quarter of the last fiscal, the company said in a filing to the BSE.

The company said that the result was not comparable as AstraZeneca group companies had acquired the global diabetic business of Bristol Myers Squibb Company.

Consequent to the acquisition, it had entered into a consignment sale agreement with Bristol Myers Squibb India for a transition period from February 1, 2014, to May 31, 2014, after which the company is directly selling these products.

Shares in AstraZeneca, on Monday, ended at Rs 912.15 apiece on the BSE, up 4.85 per cent from the previous close.